Journal for ImmunoTherapy of Cancer (Aug 2021)

Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response

  • Yong He,
  • Shusen Zheng,
  • Shuai Wang,
  • Jianxiang Chen,
  • Lele Zhang,
  • Jiacheng Huang,
  • Xiaona Chen,
  • Caixu Pan,
  • Rong Su,
  • Danjing Guo,
  • Shengyong Yin,
  • Yiting Qiao

DOI
https://doi.org/10.1136/jitc-2021-003132
Journal volume & issue
Vol. 9, no. 8

Abstract

Read online

No abstracts available.